Oct 232013
Ranbaxy Laboratories has secured approval from India’s Central Drugs Standard Control Organisation (CDSCO) to produce and market its Synriam drug in the country to treat malaria caused by the Plasmodium vivax parasite in adults.
Ranbaxy obtains approval to market malaria drug in India CLICK HERE
Sorry, the comment form is closed at this time.